ARCHIVES

Clinical Trials Approved By NCI Listed For September

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Tomasi To Resign As Roswell Park President; Committee To Study NIH Grant Review Issues

December 15, 1995

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

Kennedy Bills Would Authorize Senior Scientist Service, New Foundation, Construction Grants

July 28, 1989

Continuing Resolution Expires March 27; NIH, NCI Hope For Budget Compromise

March 15, 2013

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001